Maegim한국어

케이엠제약

225430KOSDAQSector: Chemicals & Materials
₩1,385 4.48%Market cap ₩7.7BAs of Jul 21, 2026 close · updated once daily
D
Grade D35.9 ptsTop 77% of 2,523 stocks
Financial strength
18.1
Growth momentum
48.2
Price attractiveness
47.5

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

1

Financial strength

18.1
How much debt does it carry relative to equity?
Debt-to-equity ratio
64.1%
Above median · Top 49.1% in sector
Sector median 65.0%
Can it cover what's due within a year?
Current ratio
31.7%
Below median · Top 98.3% in sector
Sector median 154.0%
How much of revenue becomes profit?
Operating margin
-18.3%
Below median · Top 93% in sector
Sector median 3.8%
How much did it earn on its own capital?
ROE (return on equity)
-14.0%
Below median · Top 87.3% in sector
Sector median 3.6%

Source filing: annual report (separate) — view original

2

Growth momentum

48.2
How much did revenue grow in a year?
Revenue growth (YoY)
10.5%
Above median · Top 23.4% in sector
Sector median 0.3%
Has it grown steadily over three years?
Revenue 3-year CAGR
0.8%
Above median · Top 41.8% in sector
Sector median -1.5%
Did core profits grow in a year?
Operating income change (YoY)
-13.8%
Below median · Top 54.9% in sector
Sector median -6.6%
Are core profits higher than three years ago?
Operating income change (3Y)
-134.5%
Below median · Top 87% in sector
Sector median -12.4%

Source filing: annual report (separate) — view original

3

Price attractiveness

47.5
Is the price expensive relative to earnings?
P/E (price-to-earnings)
Loss-making (P/E not computable)
Below median · Top 97.2% in sector
Sector median P/E of profitable peers 13.5x · 28% loss-making
Is the price expensive relative to book value?
P/B (price-to-book)
0.27x
Above median · Top 7.8% in sector
Sector median 0.69x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 266 stocks in Chemicals & Materials

S2A51B86C46D59F20